Home / Tag Archives: MTC

Tag Archives: MTC

Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014

— Innovative cardiology solutions help deliver better care for more patients, respond to biggest challenges facing cardiologists ANDOVER, Mass., Aug. 29, 2014 /PRNewswire/ – Royal Philips (NYSE: PHG AEX: PHIA) today announced its presence at the European Society of Cardiology…

Read More »

China Cord Blood Corporation Reports First Quarter Fiscal 2015 Financial Results

1Q15 Added 15,548 New Subscribers 1Q15 Revenue Up 19.1% YOY to RMB153.3 Million ($24.7 Million) 1Q15 Operating Income Up 31.1%YOY to RMB60.2 Million ($9.7 Million) Conference Call to be Held August 29, 2014 at 8:00…

Read More »

Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS

— No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug. 29, 2014 /PRNewswire/ — Takeda Pharmaceutical Company Limited ("Takeda") today announced…

Read More »

CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years

FRANKFURT AM MAIN, Germany, Aug. 29, 2014 /PRNewswire/ — The CAIDE Dementia Risk App from Merz Pharmaceuticals is available free of charge for people from 40 to 65 to calculate their individual risk for getting…

Read More »

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results

SHENZHEN, China, August 28, 2014 /PRNewswire-FirstCall/ — China Nepstar Chain Drugstore Ltd. (NYSE: NPD) (“Nepstar” or the “Company”), a leading retail drugstore chain in China based on the number of directly operated stores, today announced…

Read More »

TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension

TAIPEI, August 28, 2014 /PRNewswire/ — TWi Pharmaceuticals, Inc. (4180.TT) today announced that it has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for…

Read More »

Sihuan Pharmaceutical Announces 2014 Interim Results

Profit Attributable to Owners of the Company Up by 34.4% Leveraging Diversified Product Portfolio and Flexible Marketing Strategies Further Enhanced Profitability and Maintained Growth Momentum HONG KONG, August 27, 2014 /PRNewswire/ — Sihuan Pharmaceutical Holdings…

Read More »